Acute Myeloid Leukemia Advocacy, Education, and Support Groups

 

The following organizations provide a variety of programs, educational materials, and other forms of support for people with acute myeloid leukemia, their family members, caregivers, and friends. However, remember that this is not an endorsement of these organizations and the information they provide. You should always discuss any questions or concerns you have with your health care provider.

American Cancer Society

http://www.cancer.org

1-800-ACS-2345 (toll-free information line)

1-866-228-4327 for TTY

The American Cancer Society (ACS) is a national organization working to eradicate cancer through research, advocacy, and service.  Among its many services, the ACS has a call center that operates 24 hours a day, seven days a week, to answer questions about cancer and link callers with resources in their communities. 

CancerCare

http://www.cancercare.org

Telephone: 1-800-813-4673

E-mail: info@cancercare.org

CancerCare, founded in 1944, is a national nonprofit organization that provides free, professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs–including counseling, education, financial assistance, and practical help–are provided by trained oncology social workers and are completely free. 

M. D. Anderson Cancer Center

 http://www.mdanderson.org

1-800-392-1611 (USA)

Department of Leukemia

 http://www.mdanderson.org/diseases/adultleukemia

713-792-7305

Leukemia Insights

 http://www.mdanderson.org/publications/insights

The Leukemia Department at M. D. Anderson Cancer Center offers multiple research-based programs with new agents or strategies in ALL.  Their programs are updated on the above websites.

National Cancer Institute

http://www.cancer.gov

1-800-422-6237

TTY: 1-800-332-8615

The NCI is a federal organization and a component of the National Institute of Health. The NCI’s National Cancer Program supports and conducts research and distributes cancer information.  The website includes information about various cancer topics, research information, and cancer statistics. The website also includes a description of the NCI's initiative to eliminate cancer death and suffering by the year 2015.

Oncolink

http://www.oncolink.org

Cancer specialists from the University of Pennsylvania founded Oncolink to provide cancer information to cancer patients, health care professionals, and the general public.  The website includes information about various cancer topics, coping information, and an “Ask the Experts” section.  

The Leukemia and Lymphoma Society

http://www.leukemia-lymphoma.org

1-800-955-4572

This society funds research, education, and services involved with blood cancers.  The website includes blood cancer information, online discussion boards, and information about patient support programs, such as patient education workshops.

This content was last modified on August 11, 2007 .
Latest Cancer News
ACS Guidelines for Breast Screening with MRI May Be Excluding Some High-risk Women

January 6, 2009 — The American Cancer Society (ACS) has developed a set of guidelines to recommend which high-risk women need to undergo screening with breast magnetic resonance imaging (MRI); however, these guidelines may unwittingly exclude some women who are at a high risk of carrying the BRCA mutation yet still don’t meet the limitations set by the ACS. The results of this study were published in the journal Cancer.

Colonoscopy Fails to Identify Many Colorectal Cancers

January 6, 2009 — Colonoscopy, a standard screening method for colorectal cancer, misses the majority of cancers on the right side of the colon and about one-third of cancers on the left side of the colon, according to the results of a study published in the Annals of Internal Medicine. The researchers estimated that the screening method may reduce colorectal cancer mortality by 60-70%, rather than 90% as previously estimated.

High-dose Faslodex® Improves Time to Progression Compared with Arimidex® as Initial Therapy in Advanced Breast Cancer

January 6, 2009 — Researchers affiliated with an international trial have reported that high-dose Faslodex® (fulvestrant) significantly improves time to cancer progression compared with Arimidex® (anastrozole) as initial therapy for hormone-positive, advanced breast cancer. These results were recently presented at the 2008 annual San Antonio Breast Cancer Symposium December 10-14, 2008.

Select news items provided by Reuters Health